SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VD's Model Portfolio & Discussion Thread
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Heat Shock who wrote (6032)11/26/1998 5:46:00 AM
From: Rocketman  Read Replies (1) of 9719
 
After further thought about Stressgen's math error in their 3Q financials, I'm wondering if that primo BC Bud is as good as what the news reports say it is???? Somebody in the finance departments head ain't tightened up quite right.

Another thought, if ENMD with an interesting molecule in mice is worth $300M and Stressgen with an interesting molecule in mice is worth $40M, hmmm, maybe Stressgen needs a better PR agency with better connections to the NY Times.

Rick, you ever look at this one?

Rman
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News